On Monday, Insmed Inc (NASDAQ: INSM) opened lower -3.65% from the last session, before settling in for the closing price of $75.16. Price fluctuations for INSM have ranged from $21.92 to $80.53 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 275.45% over the last five years. Company’s average yearly earnings per share was noted -0.69% at the time writing. With a float of $174.44 million, this company’s outstanding shares have now reached $178.85 million.
The firm has a total of 912 workers. Let’s measure their productivity. In terms of profitability, gross margin is 76.51%, operating margin of -214.11%, and the pretax margin is -251.01%.
Insmed Inc (INSM) Breakdown of a Key Holders of the stock
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Insmed Inc is 2.50%, while institutional ownership is 105.22%. The most recent insider transaction that took place on Sep 13 ’24, was worth 2,072,223. In this transaction Chief Legal Officer of this company sold 27,871 shares at a rate of $74.35, taking the stock ownership to the 67,856 shares. Before that another transaction happened on Sep 13 ’24, when Company’s Chief Medical Officer sold 26,969 for $74.90, making the entire transaction worth $2,019,978. This insider now owns 106,134 shares in total.
Insmed Inc (INSM) Recent Fiscal highlights
If we go through the results of last quarter, which was made public on 9/30/2024, the company posted -1.28 earnings per share (EPS) for the quarter, coming under the agreed prediction (set at -1.13) by -0.15. Wall Street market experts anticipate that the next fiscal year will bring earnings of -1.26 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -0.69% per share during the next fiscal year.
Insmed Inc (NASDAQ: INSM) Trading Performance Indicators
Check out the current performance indicators for Insmed Inc (INSM). In the past quarter, the stock posted a quick ratio of 5.99. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 37.42.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -5.56, a number that is poised to hit -1.18 in the next quarter and is forecasted to reach -4.34 in one year’s time.
Technical Analysis of Insmed Inc (INSM)
Analysing the last 5-days average volume posted by the [Insmed Inc, INSM], we can find that recorded value of 1.26 million was lower than the volume posted last year of 2.22 million. As of the previous 9 days, the stock’s Stochastic %D was 77.50%. Additionally, its Average True Range was 2.81.
During the past 100 days, Insmed Inc’s (INSM) raw stochastic average was set at 48.25%, which indicates a significant decrease from 64.12% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 58.23% in the past 14 days, which was higher than the 37.37% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $72.13, while its 200-day Moving Average is $55.67. Now, the first resistance to watch is $74.64. This is followed by the second major resistance level at $76.85. The third major resistance level sits at $78.25. If the price goes on to break the first support level at $71.03, it is likely to go to the next support level at $69.63. Now, if the price goes above the second support level, the third support stands at $67.42.
Insmed Inc (NASDAQ: INSM) Key Stats
There are currently 178,903K shares outstanding in the company with a market cap of 12.83 billion. Presently, the company’s annual sales total 305,210 K according to its annual income of -749,570 K. Last quarter, the company’s sales amounted to 93,430 K and its income totaled -220,520 K.
